XML 38 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Operating expenses:        
Research and development $ 6,766 $ 1,992 $ 15,911 $ 3,236
Cost of in-process research and development acquired       1,607
General and administrative 2,441 1,328 6,474 2,131
Total operating expenses 9,207 3,320 22,385 6,974
Loss from operations (9,207) (3,320) (22,385) (6,974)
Other income (expense):        
Interest income (expense), net 33 1 60 (88)
Change in fair value of convertible notes payable       (183)
Total other income (expense) 33 1 60 (271)
Net loss (9,174) (3,319) (22,325) (7,245)
Other comprehensive loss:        
Unrealized loss on short-term investments (5)   (5)  
Comprehensive loss $ (9,179) $ (3,319) $ (22,330) $ (7,245)
Net loss per common share, basic and diluted $ (0.67) $ (2.98) $ (2.59) $ (10.11)
Weighted average shares outstanding used to compute net loss per share, basic and diluted 13,674,568 1,113,439 8,636,087 716,486